Research And Development Expense of Clearmind Medicine Inc. from 31 Oct 2021 to 31 Oct 2025

Taxonomy & unit
ifrs-full: USD and CAD
Summary
Clearmind Medicine Inc. quarterly and annual Research And Development Expense in USD history and change rate from 31 Oct 2021 to 31 Oct 2025.
  • Clearmind Medicine Inc. Research And Development Expense for the quarter ending 31 Oct 2025 was $420,182, a 14% decline year-over-year.
  • Clearmind Medicine Inc. Research And Development Expense for the twelve months ending 31 Oct 2025 was $2,056,525, a 49% increase year-over-year.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2025 was $2,056,525, a 49% increase from 2024.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2024 was $1,382,808, a 10% decline from 2023.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2023 was $1,544,229, a 50% decline from 2022.
Clearmind Medicine Inc. quarterly and annual Research And Development Expense in CAD history and change rate from 31 Oct 2021 to 31 Oct 2025.
  • Clearmind Medicine Inc. Research And Development Expense for the quarter ending 31 Jan 2023 was CA$792,460, a 87% increase year-over-year.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2022 was CA$4,205,245, a 550% increase from 2021.
Source SEC data
View on sec.gov
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Change (%)
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Change (%)
Research And Development Expense, Quarterly (CAD)
Research And Development Expense, YoY Quarterly Change (%)
Research And Development Expense, Annual (CAD)
Research And Development Expense, YoY Annual Change (%)

Clearmind Medicine Inc. Quarterly Research And Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,056,525 $420,182 -$66,309 -14% 01 Aug 2025 31 Oct 2025 20-F 20 Jan 2026 2025 FY
Q2 2025 $2,122,834 $723,048 +$377,165 +109% 01 May 2025 31 Jul 2025 6-K 11 Sep 2025 2025 Q3
Q1 2025 $1,745,669 $451,857 +$128,901 +40% 01 Feb 2025 30 Apr 2025 6-K 12 Jun 2025 2025 Q2
Q4 2024 $1,616,768 $461,438 +$233,960 +103% 01 Nov 2024 31 Jan 2025 6-K 13 Mar 2025 2025 Q1
Q3 2024 $1,382,808 $486,491 +$111,418 +30% 01 Aug 2024 31 Oct 2024 20-F 20 Jan 2026 2025 FY
Q2 2024 $1,271,390 $345,883 +$81,929 +31% 01 May 2024 31 Jul 2024 6-K 11 Sep 2025 2025 Q3
Q1 2024 $1,189,461 $322,956 +$5,384 +1.7% 01 Feb 2024 30 Apr 2024 6-K 12 Jun 2025 2025 Q2
Q4 2023 $1,184,077 $227,478 -$360,152 -61% 01 Nov 2023 31 Jan 2024 6-K 13 Mar 2025 2025 Q1
Q3 2023 $1,544,229 $375,073 01 Aug 2023 31 Oct 2023 20-F 20 Jan 2026 2025 FY
Q2 2023 $263,954 01 May 2023 31 Jul 2023 6-K 16 Sep 2024
Q1 2023 $317,572 -$843,186 -73% 01 Feb 2023 30 Apr 2023 6-K 13 Jun 2024
Q4 2022 $587,630 01 Nov 2022 31 Jan 2023 6-K 19 Mar 2024
Q1 2022 $1,160,758 01 Feb 2022 30 Apr 2022 6-K 14 Jun 2023

Clearmind Medicine Inc. Annual Research And Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,056,525 +$673,717 +49% 01 Nov 2024 31 Oct 2025 20-F 20 Jan 2026 2025 FY
2024 $1,382,808 -$161,421 -10% 01 Nov 2023 31 Oct 2024 20-F 20 Jan 2026 2025 FY
2023 $1,544,229 -$1,536,762 -50% 01 Nov 2022 31 Oct 2023 20-F 20 Jan 2026 2025 FY
2022 $3,080,991 +$2,607,339 +550% 01 Nov 2021 31 Oct 2022 20-F 22 Jan 2025 2024 FY
2021 $473,652 01 Nov 2020 31 Oct 2021 20-F/A 18 Mar 2024 2023 FY

Clearmind Medicine Inc. Quarterly Research And Development Expense (CAD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2022 CA$792,460 +CA$368,198 +87% 01 Nov 2022 31 Jan 2023 6-K 17 Mar 2023
Q4 2021 CA$424,262 01 Nov 2021 31 Jan 2022 6-K 17 Mar 2023

Clearmind Medicine Inc. Annual Research And Development Expense (CAD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 CA$4,205,245 +CA$3,558,758 +550% 01 Nov 2021 31 Oct 2022 20-F 06 Feb 2023 2022 FY
2021 CA$646,487 01 Nov 2020 31 Oct 2021 20-F 06 Feb 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.